Partnership between Manchester University NHS Foundation Trust and Siemens Healthineers Set to Transform Care Delivery

Siemens HealthineersManchester University NHS Foundation Trust (MFT) has selected Siemens Healthineers to enter a 15-year technology and strategic partnership. The Value Partnership includes the planning, installation, and maintenance of 222 pieces of critical medical equipment, with approximately 350 planned installations over the life of the contract. A dedicated on-site team will ensure the guaranteed technology performance and ease administrative processes for MFT by providing a single point of contact for all technology-related matters. The partnership also includes a training program for users in the imaging pathway. MFT will benefit from financial planning security over the contract period and increased availability of its technology fleet. The modern equipment is designed to improve patient care and meet growing demand for imaging as well as increase staff satisfaction and improve patient experience. This long-term partnership will enable the transformation of care delivery in the Greater Manchester area and all the communities that MFT serves. Staff will also be better prepared for future pandemics and infectious disease events. The contract is worth approximately EUR 140 million.

"This is so much more than a simple contract. It’s a 15-year Value Partnership, a relationship enabling us to provide the very best in care delivery for the people of Greater Manchester," states Catherine Walsh, Divisional Director of Imaging for MFT.

"Demand for our imaging services is increasing by 5 to 10 percent every year, yet we’ve had to reduce our throughput to deal safely with COVID-19. This new relationship gives us the confidence that we’ll be able to continue to invest in the latest technology with the flexibility to adapt it to our needs, now and into the future. All associated factors such as maintenance and budgeting are taken care of. Ultimately, the partnership will enable us to focus on delivering the best patient experience while at the same time helping us to attract and retain leading talent, and develop staff to unlock their full potential", says Walsh.

"We are pleased to enter this major partnership with MFT to support the transformation of care and drive modernisation and digitalisation of medical technology across their hospitals, directly benefitting patients in the Greater Manchester area," says Bernd Ohnesorge, President Europe, Middle East and Africa at Siemens Healthineers. "This Value Partnership represents one of the largest and broadest in scope that Siemens Healthineers has, up to now, engaged in Europe. It will also serve as an example of how innovative partnership solutions can transform care delivery for healthcare providers globally."

Manchester University NHS Foundation Trust is an NHS acute foundation trust that operates nine hospitals in Greater Manchester and is a leading provider of specialist healthcare services. It is the largest NHS trust in the UK, with revenues in excess of £1.8bn, over 2200 beds and more than 21,000 staff.

The collaboration with MFT is a Value Partnership, a long-term relationship that enables healthcare providers to optimize operations, expand capabilities and advance innovation. It draws on the company's entire Enterprise Services portfolio to add value beyond equipment. No two Value Partnerships are the same. Their design is driven entirely by the needs of the customer. A managed equipment service (MES) is a bespoke Value Partnership that provides: outsourcing of equipment ownership, risk and responsibility; future-proof access to modern, right-sized technology; value-added services that address the wider clinical environment and a one-stop, holistic solution in return for a simple, fixed unitary payment. Siemens Healthineers has established Value Partnerships with many Healthcare Providers around the world. Recent examples of Value Partnerships include Hamilton Health Sciences in Canada, the University of Missouri System in the USA, the Dallah Health Company in Saudi Arabia, and the Braunschweig Municipal Hospital in Germany.

About Siemens Healthineers AG

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...